Among patients with moderately severe Parkinson disease, exploratory biomarkers are altered in response to nilotinib, but the rate of serious adverse events (SAEs) is significantly higher in those receiving nilotinib versus placebo.
Your search for nilotinib returned 7 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
The objective of this study was to access safety and tolerability of nilotinib in participants with moderately advanced Parkinson Disease.
Nilotinib (Tasigna) improved cognition and motor skills in patients with Parkinson’s and Lewy body dementia.
Researchers say that malfunctioning of the protein tau, responsible for clearing toxins out of cells, can lead to Alzheimer’s disease and dementia.
Nilotinib (as HCl monohydrate) 50mg, 150mg, 200mg; caps; contains lactose.
Erlotinib (as HCl) 25mg, 100mg, 150mg; tabs.
A list of systemic drugs that can cause photosensitivity, including the type of reactions.
Latest News Your top articles for Wednesday
Haymarket Medical NetworkTop Picks